title: Experimental study on differences in clivus chordoma bone invasion: an iTRAQ-based quantitative proteomic analysis.
abstract: Although a bone tumor, significant differences in the extent of bone invasion exist in skull base chordoma, which directly affect the extent of surgical resection, and have an impact on its prognosis. However, the underlying mechanism of the phenomenon is not clearly understood. Therefore, we used an iTRAQ-based quantitative proteomics strategy to identify potential molecular signatures, and to find predictive markers of discrepancy in bone invasion of clivus chordoma. According to bone invasive classification criteria, 35 specimens of clivus chordoma were calssified to be either endophytic type (Type I) or exophytic type (Type II). An initial screening of six specimens of endophytic type and six of exophytic was performed, and 250 differentially expressed proteins were identified. Through the GO and IPA analysis, we found evidence that the expression of inflammatory activity-associated proteins up-regulated in endophytic type, whereas the expression of cell motility-associated proteins up-regulated in exophytic ones. Moreover, TGFβ1 and mTOR signal pathway seemed to be related with bone invasion. Thus, TGFβ1, PI3K, Akt, mTOR, and PTEN were validated in the following 23 samples by immune histochemistry and Western blot. The expression levels of TGFβ1 and PTEN were significantly lower in the endophytic type than in the exophytic ones. It was found that TGFβ1 may play an important role in its bone invasion. The mechanisms may be related with conducting an increased inflammatory cell response and a decline in cytoskeletal protein expression. PTEN is confirmed to be associated with the degree of bone invasion. The PI3K/AKT/mTOR signaling pathway might be associated with the bone invasion, but still needs a larger sample size to be verified These results, for the first time, not only demonstrate the biological changes that occur in different growth patterns from the perspective of proteomics, but also provide novel markers that may help to reveal the mechanisms behind clivus chordomas.
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Zhen
authors: Z
authors: Wu
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Liang
authors: L
authors: Wang
authors: Core Facility of Instruments, School of Basic Medicine, Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences Peking Union Medical College, Beijing, PR China.
authors: Zhengguang
authors: Z
authors: Guo
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Ke
authors: K
authors: Wang
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Yang
authors: Y
authors: Zhang
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Kaibing
authors: K
authors: Tian
authors: Dept Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing, PR China.
authors: Junting
authors: J
authors: Zhang
authors: Core Facility of Instruments, School of Basic Medicine, Chinese Academy of Medical Sciences, Institute of Basic Medical Sciences Peking Union Medical College, Beijing, PR China.
authors: Wei
authors: W
authors: Sun
authors: Dept Neurosurgery, Beijing Sanbo Brain Hospital, Capital Medical University, Beijing, PR China.
authors: Chunjiang
authors: C
authors: Yu
mesh_terms: D002817:Chordoma / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy; D003388:Cranial Fossa, Posterior / Q000473:pathology*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009361:Neoplasm Invasiveness; D063868:Patient Outcome Assessment; D011379:Prognosis; D025941:Protein Interaction Mapping; D060066:Protein Interaction Maps; D020543:Proteome; D040901:Proteomics / Q000379:methods; D015203:Reproducibility of Results; D015398:Signal Transduction; D019292:Skull Base Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology* / Q000628:therapy; D014057:Tomography, X-Ray Computed
chemical_list: D020543:Proteome